The reason is that they may set a shorter or longer beyond-use date (BUD) based on the ingredients and compounding process
Muscle mass promotes the structural integrity of our skeletal system and allows us to keep moving
We dont use a one-size-fits-all approach because we understand that your needs are unique
Semaglutides reported half-life is roughly one week, while tirzepatides is about five days
Thus, all patients were followed from study cohort entry until one of the study outcomes (described below), treatment discontinuation, initiation of a study drug in the comparator group, death from any cause (depending on the outcome), end of registration, or the end of the study period (29 March 2021), whichever came first
Some replies address the specific issue raised